These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6969919)

  • 1. [The search for anti-B cell antibodies and HLA-DR typing in Montpellier].
    Seignalet J
    Rev Fr Transfus Immunohematol; 1980 Sep; 23(4):411-25. PubMed ID: 6969919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Typing for HLA-D/DR associated DP-antigens with the primed lymphocyte typing (PLT) technique.
    Morling N; Jakobsen BK; Platz P; Ryder LP; Svejgaard A; Thomsen M
    Tissue Antigens; 1980 May; 15(5):471-82. PubMed ID: 6449760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avoidance of certain systematic pitfalls in the detection of HLA-DR antibodies defining find specificities.
    Müller C; Fink D; Müller G; Wernet P
    Tissue Antigens; 1980 Sep; 16(3):244-53. PubMed ID: 6970429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and use of high titered anti-HLA-DR sera in PHA-blast complement fixation and B-lymphocytotoxicity techniques.
    Lepage V; Gaudy Y; Terrier E; Dausset J; Colombani J
    Tissue Antigens; 1981 Jan; 17(1):37-42. PubMed ID: 6166083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A screening program for anti-DR typing reagents.
    Vassalli P; Jeannet M; de Moerloose P; Chardonnens X
    Tissue Antigens; 1979 Jan; 13(1):77-80. PubMed ID: 311089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of immune phagocytosis by human sera with HLA A, B, C and DR but not with DQ or EM type reactivity.
    Neppert J; Pohl E; Mueller-Eckhardt C
    Vox Sang; 1986; 51(2):122-6. PubMed ID: 2430362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of lymphoblastoid cell line proliferation by antisera to HLA-DR and other HLA antigens.
    Gatti RA; Cousineau M; Naeim F; Leibold W
    Tissue Antigens; 1979 Sep; 14(3):213-22. PubMed ID: 316587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisera recognising HLA-A, -B and DRW antigens raised in rhesus monkeys.
    Barnstable CJ; Snary D; Crumpton MJ; Balner H; Bodmer WF
    Tissue Antigens; 1980 May; 15(5):407-18. PubMed ID: 6160645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DR and HLA-A, B, C typing of human fetal tissue.
    Danilovs JA; Brown J; Terasaki PI; Clark WR
    Tissue Antigens; 1983 Apr; 21(4):296-308. PubMed ID: 6574618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sera from volunteers immunized by planned blood transfusions as source of DR cytotoxic typing reagents.
    Belvedere M; Richiardi P; Curtoni ES; Pellegrino MA; Ferrone S
    Immunol Commun; 1979; 8(1):93-106. PubMed ID: 311335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HLA-A, B, C and DR antibodies in renal transplant recipients.
    Akiyama N; Kusaba R; Osawa N; Inou T; Kawamura A
    Jpn J Exp Med; 1980 Jun; 50(3):205-11. PubMed ID: 7001096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic antibodies in cancer patients: possibilities of correlation with HLA antigens.
    Laurentaci G; Favoino B
    Boll Ist Sieroter Milan; 1981; 60(1):52-6. PubMed ID: 6973995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible effects of non-HLA antibodies in common typing sera on HLA antigen frequency data in leukemia.
    Pollack MS; DuBois D
    Cancer; 1977 Jun; 39(6):2348-54. PubMed ID: 301430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet absorption on the test tray (PATT): a rapid method for the screening of HLA class II antibodies using the two-colour fluorescence method.
    Cambon-Thomsen A; Sommer E; Demur C; Calot M; Ohayon E
    Tissue Antigens; 1985 Sep; 26(3):193-200. PubMed ID: 3901395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological analysis of xenogeneic anti-lymphoblastoid cell-line sera with specificity against HLA-B12.
    Schäfer K; Albert ED; Rodt H; Thierfelder S
    Immunogenetics; 1980; 10(6):595-602. PubMed ID: 22457938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated cytotoxicity against HLA-D-region products expressed in monocytes and B lymphocytes. I. Blocking by Unlabelled cells and inhibition by antisera.
    Feighery CF; Stastny P
    Immunogenetics; 1980; 10(1):31-8. PubMed ID: 6157642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved B cell typing for HLA-DR using nylon wool column enriched B lymphocyte preparations.
    Lowry R; Goguen J; Carpenter CB; Strom TB; Garovoy MR
    Tissue Antigens; 1979 Oct; 14(4):325-30. PubMed ID: 94704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DR compatibility in couples with recurrent spontaneous abortions.
    Aoki K
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Oct; 34(10):1773-80. PubMed ID: 6816873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Natural HLA-A, B and DR antibodies in the serum of non-immunized men].
    Májský A
    Vnitr Lek; 1989 May; 35(5):467-71. PubMed ID: 2763480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DR typing: some relevant difficulties.
    Borelli I; Cornaglia M; Olivetti E; Curtoni ES
    Transplant Proc; 1979 Jun; 11(2):1319-20. PubMed ID: 89736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.